These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15781016)

  • 1. Comparison of cilostazol and clopidogrel after successful coronary stenting.
    Lee SW; Park SW; Hong MK; Lee CW; Kim YH; Park JH; Kang SJ; Han KH; Kim JJ; Park SJ
    Am J Cardiol; 2005 Apr; 95(7):859-62. PubMed ID: 15781016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.
    Lee SW; Park SW; Hong MK; Kim YH; Lee BK; Song JM; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SJ
    J Am Coll Cardiol; 2005 Nov; 46(10):1833-7. PubMed ID: 16286167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
    Lee SW; Chun KJ; Park SW; Kim HS; Kim YH; Yun SC; Kim WJ; Lee JY; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Jon S; Cho YH; Lee NH; Kim JH; Park SJ
    Am J Cardiol; 2010 Jan; 105(2):168-73. PubMed ID: 20102913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
    Tanabe Y; Ito E; Nakagawa I; Suzuki K
    Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
    Mehilli J; Kastrati A; Schühlen H; Dibra A; Dotzer F; von Beckerath N; Bollwein H; Pache J; Dirschinger J; Berger PP; Schömig A;
    Circulation; 2004 Dec; 110(24):3627-35. PubMed ID: 15531766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients.
    Geng DF; Liu M; Jin DM; Wu W; Deng J; Wang JF
    Cardiology; 2012; 122(3):148-57. PubMed ID: 22832561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
    Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
    Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent.
    Chen YD; Lu YL; Jin ZN; Yuan F; Lü SZ
    Chin Med J (Engl); 2006 Mar; 119(5):360-6. PubMed ID: 16542577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions.
    Jeong YH; Park Y; Kim IS; Yun SE; Kang MK; Hwang SJ; Kwak CH; Hwang JY
    Thromb Haemost; 2010 Dec; 104(6):1286-9. PubMed ID: 20838742
    [No Abstract]   [Full Text] [Related]  

  • 11. RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome.
    Ge J; Han Y; Jiang H; Sun B; Chen J; Zhang S; Du Z;
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):162-6. PubMed ID: 16044027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
    Kamishirado H; Inoue T; Mizoguchi K; Uchida T; Nakata T; Sakuma M; Takayanagi K; Morooka S
    Am Heart J; 2002 Aug; 144(2):303-8. PubMed ID: 12177649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation.
    Kozuma K; Hara K; Yamasaki M; Morino Y; Ayabe S; Kuroda Y; Tanabe K; Ikari Y; Tamura T
    Am Heart J; 2001 Jan; 141(1):124-30. PubMed ID: 11136497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials.
    Schleinitz MD; Olkin I; Heidenreich PA
    Am Heart J; 2004 Dec; 148(6):990-7. PubMed ID: 15632883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
    Lee SW; Park SW; Yun SC; Kim YH; Park DW; Kim WJ; Lee JY; Lee CW; Hong MK; Kim JJ; Park SJ
    Am Heart J; 2010 Feb; 159(2):284-291.e1. PubMed ID: 20152228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
    Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
    Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease.
    Lee SP; Suh JW; Park KW; Lee HY; Kang HJ; Koo BK; Chae IH; Choi DJ; Rha SW; Bae JW; Cho MC; Kwon TG; Bae JH; Kim HS;
    Trials; 2010 Aug; 11():87. PubMed ID: 20735821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation.
    Gao W; Zhang Q; Ge H; Guo Y; Zhou Z
    Angiology; 2013 Oct; 64(7):554-8. PubMed ID: 23359782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporary adjunctive cilostazol vs clopidogrel loading for ST-segment elevation acute myocardial infarction.
    Tanaka A; Ishii H; Sakakibara M; Okumura S; Jinno Y; Okada K; Suzuki S; Inoue Y; Murohara T
    Am J Cardiovasc Drugs; 2014 Apr; 14(2):131-6. PubMed ID: 24452598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol and primary-PCI: mirage or good alternative?
    Porto I; D'Amario D; Crea F
    Curr Vasc Pharmacol; 2012 Jul; 10(4):468-71. PubMed ID: 22329616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.